Insmed (INSM) Research & Development (2010 - 2026)

Insmed's Research & Development history runs 17 years deep, the most recent figure standing at $209.5 million for Q1 2026.

• In Q1 2026, Research & Development rose 37.3% year-over-year to $209.5 million; the TTM figure through Mar 2026 stood at $828.0 million (up 31.46% YoY), while the FY2025 annual figure was $771.1 million, up 28.87% from the prior year.
• Research & Development was $209.5 million for Q1 2026 at Insmed, down from $254.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $254.9 million in Q4 2025 to a low of $84.4 million in Q1 2022.
• Historically, Research & Development has averaged $149.9 million across 5 years, with a median of $146.7 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development surged 122.5% in 2023, then slipped 25.5% in 2024.
• A 5-year view of Research & Development shows it stood at $124.8 million in 2022, then increased by 9.83% to $137.0 million in 2023, then soared by 31.16% to $179.7 million in 2024, then surged by 41.83% to $254.9 million in 2025, then fell by 17.82% to $209.5 million in 2026.
• The last three Research & Development figures came in at $209.5 million (Q1 2026), $254.9 million (Q4 2025), and $186.4 million (Q3 2025), per Business Quant data.